Protooncogene expression in normal and psoriatic skin
- PMID: 1688596
- DOI: 10.1111/1523-1747.ep12873313
Protooncogene expression in normal and psoriatic skin
Abstract
The expression of the c-myc, c-fos, c-jun, c-erbB, and c-Ha-ras protooncogenes was compared by Northern blot analysis of total RNA extracted from keratome biopsies of normal skin and psoriatic plaques. Isolation of intact RNA from frozen tissue required careful attention to technique during the early stages of extraction. Densitometric analysis revealed 1.5- to 2.5-fold elevations of c-myc transcript levels in lesional psoriatic relative to normal epidermis. Similar increases in cyclophilin and lipocortin II transcripts were also observed and may reflect characteristic differences in RNA preparations from normal and psoriatic epidermis. C-myc, c-jun, c-erbB, c-fos, and c-Ha-ras transcript levels were not significantly increased in lesional psoriatic epidermis when protooncogene mRNA levels were normalized to those of the cyclophilin or lipocortin genes. In contrast, transforming growth factor-alpha (TGF-alpha) transcripts were significantly increased (10- to 20-fold) with or without prior normalization. C-myc, c-fos, and c-jun transcripts were significantly induced over in vivo levels 2-4 h after organ culture of normal or psoriatic keratome biopsies, demonstrating that these genes can be highly expressed in the context of tissue injury. Our results suggest that overexpression of these protooncogenes per se is not central to the pathogenesis of psoriatic epidermal hyperplasia.
Similar articles
-
Growth factor and proto-oncogene expression in psoriasis.J Invest Dermatol. 1990 Nov;95(5 Suppl):7S-9S. doi: 10.1111/1523-1747.ep12505653. J Invest Dermatol. 1990. PMID: 16788617 Review.
-
Overexpression of transforming growth factor alpha in psoriatic epidermis.Science. 1989 Feb 10;243(4892):811-4. doi: 10.1126/science.2916128. Science. 1989. PMID: 2916128
-
Expression of the protooncogenes in psoriatic lesions.Arch Dermatol Res. 1988;280(1):8-11. doi: 10.1007/BF00412681. Arch Dermatol Res. 1988. PMID: 2451481
-
C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis.J Invest Dermatol. 1991 Oct;97(4):672-8. doi: 10.1111/1523-1747.ep12483807. J Invest Dermatol. 1991. PMID: 1940437
-
Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.J Invest Dermatol. 1995 Jul;105(1 Suppl):89S-94S. doi: 10.1111/1523-1747.ep12316121. J Invest Dermatol. 1995. PMID: 7616005 Review.
Cited by
-
Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.Eur Arch Otorhinolaryngol. 1995;252(6):366-9. doi: 10.1007/BF00178279. Eur Arch Otorhinolaryngol. 1995. PMID: 8679157
-
The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion.Clin Cosmet Investig Dermatol. 2022 Sep 27;15:2035-2043. doi: 10.2147/CCID.S385894. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36193053 Free PMC article.
-
Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.J Clin Invest. 1997 Sep 1;100(5):1271-81. doi: 10.1172/JCI119641. J Clin Invest. 1997. PMID: 9276746 Free PMC article.
-
Transcription factor regulation of epidermal keratinocyte gene expression.Mol Biol Rep. 1996;23(1):59-70. doi: 10.1007/BF00357073. Mol Biol Rep. 1996. PMID: 8983019 Review.
-
Regulation of fos-lacZ fusion gene expression in primary mouse epidermal keratinocytes isolated from transgenic mice.Biochem J. 1994 May 15;300 ( Pt 1)(Pt 1):263-70. doi: 10.1042/bj3000263. Biochem J. 1994. PMID: 8198544 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous